Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS)
Status:
Recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to investigate the hemoglobin change and association
between hemoglobin change and readmissions due to heart failure, and all-cause death in
patients with heart failure treated with dapagliflozin or placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Xiangtan Central Hospital
Collaborators:
Second Xiangya Hospital of Central South University ZhuZhou Central Hospital